← Eichor
Study identifier: NCT03400345 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Human Upper Extremity Allotransplantation: F/U Protocol

Condition: Amputation, Traumatic · Wounds and Injury · Hand Injuries  ·  Sponsor: Johns Hopkins University

PhaseN/A
Planned participants60
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersNo

About this study

Upper extremity allotransplantation is a new procedure which is becoming more common in the United States. Ongoing data collection for research purposes is vital to the long-term assessment as to the safety of the procedure and accompanying immunosuppression protocol, as well as quantifying patient outcomes and changes in quality of life. For these reasons, The Johns Hopkins Hand/Arm Transplantation Team is interested in enrolling transplanted patients in a follow-up protocol to continue collecting informative data to further the field of vascularized composite allotransplantation.

This description comes directly from the study's public registry record.

Talk to the study team

Jane Littleton, C.R.N.P  ·  410-955-6875  ·  jlittl38@jhmi.edu

TBD TBD  ·  443-287-7848

Always discuss trial participation with your own doctor first.

Locations (1)

Johns Hopkins University School of MedicineBaltimore, Maryland, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03400345